Market Cap (In TWD)
11.44 Billion
Revenue (In TWD)
-
Net Income (In TWD)
-306.08 Million
Avg. Volume
265.23 Thousand
- Currency
- TWD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 49.0-72.3
- PE
- -
- EPS
- -
- Beta Value
- 0.093
- ISIN
- TW0006586001
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Chung-Yi Wu Ph.D.
- Employee Count
- -
- Website
- https://www.chopharma.com
- Ipo Date
- 2017-09-28
- Details
- CHO Pharma, Inc., a biopharmaceutical company, develops and commercializes therapeutic and diagnostic products for the unmet clinical needs. It is developing homogeneous antibody drugs, such as CHO-H01, CHO-H02, and CHO-A04, a humanized monoclonal antibody for cancer; CHO-H03, a homogeneous antibody drug for autoimmune diseases; CHO-S05 dual-effect anti-flu drugs; and CHO-V08 for Klebsiella pneumonia. The company was founded in 2012 and is based in Taipei City, Taiwan.
More Stocks
-
BHANDARIBhandari Hosiery Exports Limited
BHANDARI
-
COICConcentric AB (publ)
COIC
-
CARA
-
PKX
-
BITTIBittium Oyj
BITTI
-
COGN3Cogna Educação S.A.
COGN3
-
FIVFiserv, Inc.
FIV
-
KOTHARIPROKothari Products Limited
KOTHARIPRO